Praxis Precision Medicines, Inc. Share Price
Equities
PRAX
US74006W2070
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 343.20 USD | +3.43% |
|
+2.97% | +16.44% |
| Capitalization | 9.57B 8.16B 7.48B 7.08B 13.13B 916B 13.25B 89.14B 34.71B 434B 35.9B 35.15B 1,509B | P/E ratio 2026 * |
-22.9x | P/E ratio 2027 * | -32.3x |
|---|---|---|---|---|---|
| Enterprise value | 8.69B 7.42B 6.8B 6.44B 11.93B 832B 12.04B 81B 31.54B 395B 32.62B 31.94B 1,371B | EV / Sales 2026 * |
2,241x | EV / Sales 2027 * | 27.7x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Praxis Precision Medicines, Inc.
| 1 day | +3.43% | ||
| 1 week | +2.97% | ||
| Current month | +7.64% | ||
| 1 month | +8.56% | ||
| 3 months | +3.09% | ||
| 6 months | +86.92% | ||
| Current year | +16.44% |
| 1 week | 317.92 |  | 353 |
| 1 month | 310 | | 353 |
| Current year | 266.93 | | 356 |
| 1 year | 35.21 | | 356 |
| 3 years | 12.45 | | 356 |
| 5 years | 11.85 | | 356 |
| 10 years | 11.85 | | 914.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Petrou
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2017 |
Marcio Souza
CEO | Chief Executive Officer | 47 | 31/03/2020 |
| Director of Finance/CFO | 53 | 24/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
William Young
BRD | Director/Board Member | 81 | 30/11/2016 |
Dean Mitchell
CHM | Chairman | 70 | 16/09/2020 |
Marcio Souza
BRD | Director/Board Member | 47 | 31/03/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.43% | +2.97% | +793.28% | +2,100.00% | 9.25B | |
| +0.27% | -2.47% | -16.97% | -16.79% | 43.3B | |
| +1.39% | +5.91% | +35.08% | +32.18% | 34.55B | |
| +1.09% | -1.01% | +247.95% | +463.28% | 30.65B | |
| +0.87% | -0.77% | +12.12% | -6.97% | 28.97B | |
| +1.05% | -2.28% | +32.43% | +26.70% | 27.29B | |
| -0.43% | +5.49% | - | - | 14.82B | |
| -3.59% | -3.37% | +113.03% | +4,035.93% | 13.51B | |
| +0.60% | +0.77% | +126.16% | +113.55% | 12.46B | |
| +1.16% | +0.78% | +5.45% | -1.33% | 12.13B | |
| Average | +0.58% | +0.79% | +149.84% | +749.61% | 22.69B | |
| Weighted average by Cap. | +0.64% | +0.76% | +93.42% | +426.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.88M 3.31M 3.04M 2.87M 5.32M 371M 5.38M 36.15M 14.08M 176M 14.56M 14.25M 612M | 313M 267M 245M 232M 430M 29.96B 434M 2.92B 1.14B 14.21B 1.17B 1.15B 49.38B |
| Net income | -436M -372M -341M -323M -598M -41.75B -604M -4.06B -1.58B -19.8B -1.64B -1.6B -68.8B | -311M -265M -243M -230M -427M -29.77B -431M -2.9B -1.13B -14.12B -1.17B -1.14B -49.07B |
| Net Debt | -874M -745M -684M -647M -1.2B -83.65B -1.21B -8.14B -3.17B -39.68B -3.28B -3.21B -138B | -904M -771M -707M -670M -1.24B -86.56B -1.25B -8.43B -3.28B -41.06B -3.39B -3.32B -143B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/05/26 | 343.20 $ | +3.43% | 426,047 |
| 11/05/26 | 331.81 $ | +0.54% | 749,051 |
| 08/05/26 | 330.02 $ | -0.98% | 339,039 |
| 07/05/26 | 333.28 $ | -1.42% | 457,696 |
| 06/05/26 | 338.07 $ | +1.43% | 361,057 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PRAX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition